3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
40
Lymphoma, Mantle-Cell
27
Lymphoma
26
Lymphoma, Follicular
25
Lymphoma, Non-Hodgkin
23
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, B-Cell
14
Lymphoma, B-Cell, Marginal Zone
13
Burkitt Lymphoma
12
Recurrence
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Waldenstrom Macroglobulinemia
6
Leukemia, Hairy Cell
5
Lymphoproliferative Disorders
4
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Infections
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Epstein-Barr Virus Infections
2
Interventions
ruxolitinib
9
fludarabine phosphate
8
fludarabine
8
Whole-Body Irradiation
8
Specimen Handling
7
Cytarabine
7
Cyclophosphamide
7
Mycophenolic Acid
6
Tacrolimus
5
Injections
5
Busulfan
5
Biopsy
5
Azacitidine
5
Stem Cell Transplantation
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
CPX-351
4
venetoclax
3
luspatercept
3
decitabine and cedazuridine drug combination
3
Liposomes
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Blood Specimen Collection
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
selinexor
2
nilotinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Rituximab
×
90 days
×
Clear all
No trials found.